 For Part 2, patients with CNS metastases treated stereotactic radio-surgery SRS, andor surgery who are considered stable by CNS imaging for at least 2 months prior to enrollment and are not being treated with corticosteroids 6 weeks prior to study day 1 may be enrolled. 